Niraj Varma, MD, PhD, an electrophysiologist at Cleveland Clinic, performed the first U.S. implant of Biotronik’s Acticor Sky DX cardiac resynchronization therapy defibrillator, the company announced Oct. 6.
Dr. Varma’s procedure came shortly after the FDA approved Biotronik’s Acticor Sky and Rivacor Sky device families.
Dr. Varma said one thing stood out to him as the first U.S. physician to implant the device: it supports physiologic pacing and also alerts clinicians when heart failure is getting worse.
“This combination may have a real impact on how CRT-D therapy is delivered across the U.S.,” Dr. Varma said.
The device Dr. Varma implanted supports left bundle branch area pacing workflows. It also adjusts heart rate through the autonomic nervous system using Closed Loop Stimulation. Its DX Technology uses two leads with true atrial sensing, which Biotronik says shortens procedures and reduces hardware burden.
The system also includes two other features. HeartInsight combines several measurements into one alert for worsening heart failure. MRI Guard 24/7 means patients no longer need programming appointments before and after an MRI.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
